Assignment Vinge advises Oncopeptides in connection with a directed share issue

June 28, 2019

The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncopeptides will raise proceeds of approximately SEK 727 million, before issue costs.

The share issue is directed to a number of selected international and Swedish reputable investors and life sciences specialist investors, on the basis of an accelerated bookbuilding process conducted by Carnegie Investment Bank AB (publ), Cowen, DNB Markets, a part of DNB Bank ASA, Jefferies International Limited and Kempen & CO N.V.

Oncopeptides is a clinical development pharmaceutical company focused on conducting anti-cancer research to develop treatments for the benefit of patients. The company’s shares are admitted to trading on Nasdaq Stockholm.

Vinge’s team has consisted of Dain Hård Nevonen, Sofie Bjärtun and Hampus Olsson.

Employment law podcast – our first episode in English

By popular request, here is our very first English-language episode of Vinge's employment law podcast Arbetsrättspodden.
November 28, 2019

Viveka Classon new partner in Stockholm

Viveka Classon has been elected as a new partner at Vinge’s Stockholm office.
November 14, 2019

Maria-Pia Hope wins the Swedish Bar Association’s award for outstanding work within the legal profession

For the eighth year in a row, the Swedish Bar Association has issued the award for outstanding achievements within the legal profession. In 2019, the award goes to Maria-Pia Hope, Managing Partner at Advokatfirman Vinge.
October 25, 2019